UPS is a full service transportation and logistics company. They can deliver everything from standard packages to temperature-controlled goods throughout the U.S. and around the world. They recently expanded their services to include transportation of biomeds and other dangerous specimens through their International Special Commodities (ISC) program. Other logistics companies do offer this service, but they do not have the existing network in place that UPS has spent decades creating.
UPS Vice President John Menna said, “This expansion is a direct response to growing customer demand from biopharmaceutical manufacturers, diagnostic companies, and laboratories to use UPS’s best-in-class and secure global network for sending specialized commodities to and from more destinations. The ability to reliably transport biologics and dangerous goods in excepted quantities are an integral part of UPS’s growth strategy supporting the healthcare industry, and we are committed to providing the right solutions and going where our customers demand we go.”
The ISC program includes 20 international destinations including Australia, Bulgaria, India, New Zealand, Russia, Saudi Arabia, South Africa, Ukraine, and more. All packages comply with UN 3373 Biological Substances, Category B. Diagnostic Specimen and Clinical Specimen regulations. Precautions are put in place to maintain biomed status at all times.
The pharmaceutical industry is fast growing and they need more reliable transportation to handle their special commodities. That’s why UPS got involved in the project. At the heart of UPS’s service is temperature-sensitive storage, packing, and transportation. They use dry ice and refrigerated units to control the temperature of goods to cryogenic levels. Everything is monitored and controled for loss prevention. There are currently 49 dedicated healthcare facilities for UPS’s ISC program.
UPS is a leader in temperature-controlled logistics. Other transportation and logistics companies are expected to step up and compete in the market as the pharmaceutical industry continues to grow and the need for specialized commodity transportation is needed.